rs150710061
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 2P and 3B. PM1BP4_ModerateBS2_Supporting
The NM_000016.6(ACADM):āc.1091T>Cā(p.Ile364Thr) variant causes a missense change. The variant allele was found at a frequency of 0.000432 in 1,614,006 control chromosomes in the GnomAD database, including 4 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I364V) has been classified as Uncertain significance.
Frequency
Consequence
NM_000016.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACADM | NM_000016.6 | c.1091T>C | p.Ile364Thr | missense_variant | 11/12 | ENST00000370841.9 | NP_000007.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000328 AC: 50AN: 152212Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000478 AC: 120AN: 251302Hom.: 2 AF XY: 0.000560 AC XY: 76AN XY: 135800
GnomAD4 exome AF: 0.000443 AC: 647AN: 1461794Hom.: 4 Cov.: 31 AF XY: 0.000490 AC XY: 356AN XY: 727210
GnomAD4 genome AF: 0.000328 AC: 50AN: 152212Hom.: 0 Cov.: 32 AF XY: 0.000377 AC XY: 28AN XY: 74354
ClinVar
Submissions by phenotype
Medium-chain acyl-coenzyme A dehydrogenase deficiency Uncertain:4
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | May 11, 2022 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score, this variant could not be ruled out of causing disease and therefore its association with disease required further investigation. A literature search was performed for the gene, cDNA change, and amino acid change (if applicable). No publications were found based on this search. This variant was therefore classified as a variant of unknown significance for this disease. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 17, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 364 of the ACADM protein (p.Ile364Thr). This variant is present in population databases (rs150710061, gnomAD 0.1%), including at least one homozygous and/or hemizygous individual. This missense change has been observed in individual(s) with abnormal newborn screening results suggestive of MCAD deficiency (PMID: 27308838). ClinVar contains an entry for this variant (Variation ID: 92253). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ACADM protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Jun 12, 2023 | - - |
not provided Uncertain:3
Uncertain significance, criteria provided, single submitter | clinical testing | GeneDx | Dec 06, 2024 | In silico analysis indicates that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 27308838, 29247206, 34426522, 36840705, 33580884) - |
Uncertain significance, criteria provided, single submitter | clinical testing | Mayo Clinic Laboratories, Mayo Clinic | Aug 13, 2020 | - - |
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Oct 22, 2015 | - - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 10, 2024 | The c.1091T>C (p.I364T) alteration is located in exon 11 (coding exon 11) of the ACADM gene. This alteration results from a T to C substitution at nucleotide position 1091, causing the isoleucine (I) at amino acid position 364 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ACADM-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 26, 2024 | The ACADM c.1091T>C variant is predicted to result in the amino acid substitution p.Ile364Thr. This variant has been reported, along with known causative ACADM c.985A>G (p.Lys329Glu), in at least two individuals with concern for medium chain acyl CoA dehydrogenase deficiency (MCADD, Boemer et al. 2017. PubMed ID: 29247206; Weiss et al. 2023. PubMed ID: 36840705). This variant is reported in 0.13% of alleles in individuals of South Asian descent in gnomAD, including two homozygotes. This variant has conflicting interpretations by other laboratories in the ClinVar database ranging from likely benign to uncertain (https://www.ncbi.nlm.nih.gov/clinvar/variation/92253/). At PreventionGenetics, we have observed this variant in the compound heterozygous state with pathogenic p.Lys329Glu variant in at least three unrelated individuals undergoing testing for MCADD (internal data). However, the c.985A>G (p.Lys329Glu) variant, in the heterozygous state without a second ACADM variant, has been reported to lead to false positive newborn screen results suggestive of MCADD (Merritt and Chang. 2019. PubMed ID: 20301597). Taken together, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at